Pharmacy Report Archives - Page 45 of 151 - Becker's Hospital Review

Mark Cuban co. imports penicillin | 1st Lyme disease vaccine in phase 3 trials | 10 systems seeking pharmacy leaders | Study ties Ozempic to low dementia risk | Are meeting-free Fridays the future?

July 18, 2024 BHR Newsletter 1. Pfizer, Valneva inch closer to FDA approval of 1st Lyme disease vaccine Full story 2. From AI to residencies, ASHP passes 16 new policies Full story 3. Mark Cuban's company to import antibiotic in short…

Pass rates for 7 pharmacy certifications | Weight loss expert's thoughts on 1st GLP-1 generic | Police probe illicit drugs at Ore. hospital | Cancer drug shortage: 8 updates | Rite Aid reports security breach

July 17, 2024 BHR Newsletter 1. How NYU Langone's bariatric surgery chief is thinking about the first GLP-1 generic Full story 2. Cancer drug shortage: 8 updates Full story 3. Pass rates for 7 pharmacy specialty certifications Full story 4.…

A $38M loss of hospital drugs | Tips for pharmacy execs seeking a promotion | Drug candidate shrank melanoma tumors by 70% | FDA: Conserve blood culture vials | Best hospitals by state: US News

July 16, 2024 BHR Newsletter 1. Hospitals wasted $38M worth of medications in 2 years: Report Full story 2. FDA urges conservation measures amid blood culture vial shortage Full story 3. Drug therapy shows promise in eliminating melanoma tumors Full…

Baptist's journey to a $40M pharmacy | Hikma probes IV bag wraps | Growing demand for clinical pharmacists: LinkedIn | 8 updates on GLP-1s | Yale New Haven launches mobile pharmacy

July 15, 2024 BHR Newsletter 1. From 'unnecessary expense' to industry leader: Baptist's pharmacy journey Full story 2. ISMP warns about mislabeled IV bag overwraps Full story 3. Trump treated at Butler Memorial after assassination attempt Full story 4. Common…

Pharmacists should be providers: Northwell exec | FTC might sue 3 PBMs | 10 systems seeking pharmacy leaders | Grocery chain merger won't close pharmacies | Pfizer tests obesity GLP-1 pill

July 11, 2024 BHR Newsletter 1. Arbitrary drug expiration dates increase waste, costs: Study Full story 2. Stores sold in Kroger, Albertsons merger to keep pharmacy, healthcare services Full story 3. UnitedHealth, CVS, Cigna to face FTC lawsuit over PBM…

FTC leaders decry PBM report | 6 new drug shortages | Hospital pharma expenses grow 8.3% | GLP-1s spur clinic's closure | Kansas sued over 340B law

July 10, 2024 BHR Newsletter 1. 6 drugs now in shortage Full story 2. Calls from inside the house: FTC commissioners criticize report on PBMs Full story 3. 'The era of the GLP-1': Obesity drugs' next play Full story 4. Common pharmacy…

PBMs causing 'dire consequences': FTC | Ozempic v. Mounjaro | HIV drug results in zero infections | RI law blocks white bagging | Eli Lilly eyes $3.2B purchase | CAR-T drug costs more in hospitals: Study

July 9, 2024 BHR Newsletter 1. CAR-T therapy for Medicare patients costs more in hospital: Study Full story 2. HIV prevention drug touts zero infections in 3 years Full story 3. The 'dire consequences' of PBM operations Full story 4.…

Cancer drug tested against COVID | Floating pharmacists 'not a solution': APhA CEO | 2 Ozempic studies | Losartan boosts chemotherapy in study | A challenge for future leaders

July 8, 2024 BHR Newsletter 1. Floating pharmacists 'not a solution,' APhA CEO says Full story 2. Ozempic may lower risk for certain cancers: Study Full story 3. Researchers explore fighting COVID-19 with a cancer drug Full story 4. Healthcare's overreliance…

New Alzheimer's drug approved | Cisplatin tied to hearing loss: Study | Ohio system to scoop pharmacy | 10 systems seeking pharmacy leaders | Feds probe 4 health systems

July 3, 2024 BHR Newsletter 1. FDA approves Eli Lilly Alzheimer's drug Full story 2. Common cancer drug linked to hearing loss: Study Full story 3. Ohio system to scoop local pharmacy Full story 4. What's really keeping healthcare executives…

FTC probes Teva | The GLP-1 coverage dilemma | PhRMA loses petition in 340B case | Drug researcher charged in $16M fraud case | How Chevron ruling could hurt pharma | Moderna gets $176M to make mRNA flu shots

July 2, 2024 BHR Newsletter 1. FTC probes Teva over drug patents Full story 2. Chevron ruling may hinder drug development, experts say Full story 3. Moderna gets $176M to develop mRNA flu shots Full story 4. Turn a crisis…